Citation Impact
Citing Papers
Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
2015
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
2017 Standout
Rationally engineered Cas9 nucleases with improved specificity
2015 StandoutScience
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
2017
Network based elucidation of drug response: from modulators to targets
2013
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling
2011
The aryl hydrocarbon receptor as a target of environmental stressors – Implications for pollution mediated stress and inflammatory responses
2020
A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection
2017
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
2016
Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
2019 Standout
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
2011 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
ETS gene fusions in prostate cancer
2009
A view on drug resistance in cancer
2019 StandoutNature
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
2014
Identification and functional analysis of 9p24 amplified genes in human breast cancer
2011
Translating cancer research into targeted therapeutics
2010 Nature
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
2012 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of the Human Endogenous Coregulator Complexome
2011
The Human Transcription Factors
2018 Standout
The ETS family of oncogenic transcription factors in solid tumours
2017
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
2013
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets
2014
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Antibody therapy of cancer
2012 Standout
Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles
2020
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
High-Throughput Approaches to Pinpoint Function within the Noncoding Genome
2017
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
2016 Standout
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
2016
Drug repurposing: progress, challenges and recommendations
2018 Standout
Cyclin D as a therapeutic target in cancer
2011
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Development and Applications of CRISPR-Cas9 for Genome Engineering
2014 Standout
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
2016 StandoutNobel
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Direct mutation analysis by high-throughput sequencing: From germline to low-abundant, somatic variants
2011
Mutagenicity and DNA Adduct Formation by the Urban Air Pollutant 2-Nitrobenzanthrone
2007
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing
2013
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
2014 Standout
Recurrent gene fusions in prostate cancer
2008
Clonal evolution in cancer
2012 StandoutNature
The Hallmarks of Aging
2013 Standout
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
2014
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
2020 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
2020 StandoutNobel
Exploring the Genomes of Cancer Cells: Progress and Promise
2011 Science
Regulatory T Cells and Human Disease
2020 StandoutNobel
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Tumor clone dynamics in lethal prostate cancer
2014
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
2017
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
2013 Standout
Rational Tuning of Fluorobenzene Probes for Cysteine‐Selective Protein Modification
2018 StandoutNobel
Diverse Functional Roles of Reactive Cysteines
2012
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
A New Initiative on Precision Medicine
2015 Standout
Cancer Genome Landscapes
2013 StandoutScience
Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution
2016
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
CAR T cell immunotherapy for human cancer
2018 StandoutScience
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
2018 Standout
Works of Daniel Brewer being referenced
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer
2008
Detection of TMPRSS2-ERG Translocations in Human Prostate Cancer by Expression Profiling Using GeneChip Human Exon 1.0 ST Arrays
2007
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance
2008
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study
2012
Expression profiling of CD133+ and CD133— epithelial cells from human prostate
2008
Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer
2012
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
2010
Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2
2006
Ranked prediction of p53 targets using hidden variable dynamic modeling
2006
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
2013
A census of amplified and overexpressed human cancer genes
2009
Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation
2011
Poly(amidoamine) Dendrimer Nanocarriers and Their Aerosol Formulations for siRNA Delivery to the Lung Epithelium
2014